Photodynamic Therapy Incubation Times for Actinic Keratosis
NCT: NCT03066843 · COMPLETED
Brief Summary
This is a randomized clinical trial evaluating blue light 5-aminolevulinic acid (ALA) photodynamic therapy with different incubation times for the treatment of actinic keratosis. Subjects who are interested in participating, currently living in the Chicago metropolitan area, and meet inclusion and exclusion criteria will be enrolled in the study. Subjects will be randomized to either 1) zero time ALA incubation or 2) 1 hour ALA incubation. Demographic and health data will be collected prior to treatment initiation. Three visits will be conducted: screening, treatment, and follow up visit at 8 weeks. This study is a pilot study designed to determine feasibility of this procedure.
Frequently Asked Questions
What is Photodynamic Therapy Incubation Times for Actinic Keratosis?
Photodynamic Therapy Incubation Times for Actinic Keratosis is a clinical trial registered under NCT03066843. Current status: COMPLETED.
What is the status of NCT03066843?
The current status of NCT03066843 (Photodynamic Therapy Incubation Times for Actinic Keratosis) is: COMPLETED.
When did Photodynamic Therapy Incubation Times for Actinic Keratosis start?
Photodynamic Therapy Incubation Times for Actinic Keratosis started on 2017-03-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.